SEC Form 4 · accession 0000357097-15-000008
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly M. Smith
Officer — Interim CFO/Treas/Secy
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2,F1 | $3.53 | Jan 20, 2015 | A | 35,000 | A | — | Jan 20, 2025 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The options set forth in this table vest in four 8,750 share increments on January 20, 2016, 2017, 2018 and 2019 provided the reporting person is employed by the Company on each vesting date.
- F2The options were issued in connection with the reporting person's employment service to the Company.